vom 13.06.2024

NCT Run 2024: Run for a good cause, 5-7 July

From 5 to 7 July, runners from all over the world can take part in the 13th NCT Run. Proceeds from the charity event will benefit innovative projects in applied cancer research at the National Centre for Tumour Diseases (NCT) in Heidelberg - www.nct-lauf.de. For the first time, the Bahnstadtlauf is a partner of the NCT Run and one kilometre of the course will automatically count towards the NCT Run.


The NCT Heidelberg is a joint institution of the German Cancer Research Centre (DKFZ) and Heidelberg University Hospital (UKHD).

It's almost time for the NCT Run 2024, a three-day run for a good cause from 5 to 7 July. Whether walking, hiking or jogging is up to everyone, and the distance and course can be freely chosen. As in previous years, start locations will be spread around the world and the run will be organised in a shared online community.

Registration for the event is free and can be done online at www.nct-lauf.de. The toolbox for the event can also be found at the same address and includes print templates for shirts, personalised bibs and a map with all the start locations. The starting signal for the NCT Run 2024 will be symbolically given on 5 July on the social media channels of the NCT Heidelberg.

The organisers have set a target of 40,000 kilometres. As the main sponsor, SAP will donate €0.50 for every kilometre until this goal is reached. The patron of the event is the Lord Mayor of Heidelberg, Eckart Würzner.

This year, for the first time, the Bahnstadtlauf is a partner of the NCT Run. Anyone who likes to run with others, or is just looking for some competition, can take part in the Bahnstadtlauf. The 2.5-kilometre course is marked with an NCT Run kilometre, which every participant automatically contributes to the common goal. Anyone who is also registered for the NCT Run can have the entire distance of the Bahnstadtlauf counted towards the NCT Run.

Dirk Jäger, Managing Director of the NCT Heidelberg and Head of the Department of Medical Oncology at Heidelberg University Hospital (UKHD), says: "The NCT Run gets people moving. That in itself is a good thing. What's more, the active runners are committed to a good cause with their exercise and their participation in the charity run helps to advance our work for our patients at the NCT Heidelberg."

The NCT Run is taking place for the 13th time this year. Since it was first held in 2012, more than 50,000 people have run around 570,000 kilometres - the equivalent of 14 times around the world. Until 2019, the NCT Run was held in Neuenheimer Feld in Heidelberg. Since 2020, people on all seven continents have been running in an online community. The NCT Run has raised almost one million euros in donations since its inception.

Stefan Fröhling, Managing Director of the NCT Heidelberg and Head of the Department of Translational Medical Oncology at the German Cancer Research Centre (DKFZ), says: "By taking part in the NCT Run, the athletes are supporting us in our goal of being able to treat cancer better and more effectively. The run and the funds raised directly contribute to our ability to carry out innovative, applied cancer research at the NCT Heidelberg.


Facts and figures

Friday 5 July (00:00) to Sunday 7 July 2023 (24:00)

Symbolic launch:  
5 July, on Facebook and Instagram

Online at www.nct-lauf.de

Entry fee:              
Free of charge. Donations to the NCT Heidelberg are requested.

Fundraising campaign:        
Personal fundraising campaigns can be started on the NCT website: www.nct-heidelberg.de/spendenaktion

Can be chosen freely. The kilometres covered are entered manually online using the personal access data.

Regina Hohmann, Tel: 06221 56-36146, regina.hohmann@nct-heidelberg.de
Andreas Klein, Tel: 06221 42-5448, andreas.klein@nct-heidelberg.de

University Hospital Heidelberg (UKHD)

Take part:              
Participants can share their personal NCT run on social media using #nctlauf and #nctrun. Alternatively, they can send photos and videos directly to the organisers: fundraising@nct-heidelberg.de

NCT fundraising account:
National Centre for Tumour Diseases (NCT) Heidelberg, Germany
LBBW Stuttgart
IBAN: DE64 6005 0101 7421 5004 29
Reference (please always specify) D 100 70680

Partner of the 2024:            
Bahnstadtlauf, https://heidelberger-tv.de/bahnstadtlauf/
Registration with costs


A picture of the press release is available free of charge at



Usage information for image material for press releases

Use is free of charge. The NCT Heidelberg authorises one-time use in connection with reporting on the topic of the press release. Please indicate the copyright "NCT Heidelberg" as picture credits. The image material may only be passed on to third parties after prior consultation with NCT Communications (phone: +49 6221 42-1755, e-mail: martin.staiger@nct-heidelberg.de). Use for commercial purposes is prohibited.

Press contact:

Dr. Martin Staiger
Nationales Centrum für Tumorerkrankungen (NCT) Heidelberg
Kommunikation und Veranstaltungen
Im Neuenheimer Feld 460
69120 Heidelberg
Tel.: +49 6221 42-1755
E-Mail: martin.staiger@nct-heidelberg.de

Dr. Sibylle Kohlstädt
Deutsches Krebsforschungszentrum (DKFZ)
Strategische Kommunikation und Öffentlichkeitsarbeit
Im Neuenheimer Feld 280
69120 Heidelberg
Tel.: +49 6221 42-2843
Fax: +49 6221 42-2968
E-Mail: s.kohlstaedt@dkfz.de

Dr. Stefanie Seltmann
Universitätsklinikum Heidelberg und Medizinische Fakultät der Universität Heidelberg
Presse- und Öffentlichkeitsarbeit
Im Neuenheimer Feld 672
69120 Heidelberg
Tel.: +49 6221 56-5052
Fax: +49 6221 56-4544
E-Mail: stefanie.seltmann@med.uni-heidelberg.de


German Cancer Research Center (DKFZ)

With more than 3,000 employees, the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) is Germany’s largest biomedical research institute. DKFZ scientists identify cancer risk factors, investigate how cancer progresses and develop new cancer prevention strategies. They are also developing new methods to diagnose tumors more precisely and treat cancer patients more successfully. The DKFZ's Cancer Information Service (KID) provides patients, interested citizens and experts with individual answers to questions relating to cancer.

To transfer promising approaches from cancer research to the clinic and thus improve the prognosis of cancer patients, the DKFZ cooperates with excellent research institutions and university hospitals throughout Germany:

  • National Center for Tumor Diseases (NCT, 6 sites)
  • German Cancer Consortium (DKTK, 8 sites)
  • Hopp Children's Cancer Center (KiTZ) Heidelberg
  • Helmholtz Institute for Translational Oncology (HI-TRON Mainz) - A Helmholtz Institute of the DKFZ
  • DKFZ-Hector Cancer Institute at the University Medical Center Mannheim
  • National Cancer Prevention Center (jointly with German Cancer Aid)

The DKFZ is 90 percent financed by the Federal Ministry of Education and Research and 10 percent by the state of Baden-Württemberg. The DKFZ is a member of the Helmholtz Association of German Research Centers.


The National Center for Tumor Diseases (NCT) Heidelberg

The National Center for Tumor Diseases (NCT) Heidelberg is a joint institution of the German Cancer Research Center, Heidelberg University Hospital and German Cancer Aid. The NCT's goal is to link promising approaches from cancer research with patient care from diagnosis to treatment, aftercare and prevention. The interdisciplinary tumor outpatient clinic is the central element of the NCT. Here the patients benefit from an individual treatment plan prepared in a timely manner in interdisciplinary expert rounds, the so-called tumor boards. Participation in clinical studies provides access to innovative therapies. The NCT thereby acts as a pioneering platform that translates novel research results from the laboratory into clinical practice. The NCT cooperates with self-help groups and supports them in their work. The pediatric oncologists at the KiTZ work together in joint structures with the NCT Heidelberg.


Heidelberg University Hospital and Faculty of Medicine: Internationally Renowned Patient Care, Research and Teaching

Heidelberg University Hospital (Universitätsklinikum Heidelberg, UKHD) is one of the largest and most prestigious medical centers in Germany. The Medical Faculty of Heidelberg University (Medizinische Fakultät Heidelberg, MFHD) belongs to the internationally renowned biomedical research institutions in Europe. Both institutions have the common goal of developing new therapies and implementing them rapidly for patients. Heidelberg University Hospital and the Medical Faculty of Heidelberg University employs around 14.500 employees and is committed to providing trainings and qualifications. Every year, around 86,000 patients and more than 1.100.000 outpatient cases are treated in more than 50 clinical departments with almost 2.500 beds. Together with the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) and the German Cancer Aid, the UKHD established the first National Center for Tumor Diseases (NCT) in Heidelberg. The goal is to provide care at the highest level as an oncology center of excellence and to rapidly transfer promising approaches from cancer research to the hospital. In addition, the UKHD operates in partnership with the DKFZ and the University of Heidelberg the Hopp Children’s Cancer center Heidelberg (KiTZ), a unique and nationally known therapy and research center for oncological and hematological diseases in children and adolescents. The Heidelberg Curriculum Medicinale (HeiCuMed) is one of the top medical training programs in Germany. Currently, there are about 4.000 future physicians studying in Heidelberg.